Denmark Extends AstraZeneca COVID-19 Vaccine Suspension for Three Weeks

Denmark has extended its suspension of AstraZeneca vaccines for three weeks, despite advice from the European Medicines Agency (EMA).

All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

***

Below is the report of EuroNews confirming Denmark’s Decision to Suspend the Astrazeneka Vaccine.

The Danish Health and Medicines Authority said they were still assessing the use of the jab in its vaccination programme.  

Earlier this month, Denmark and several other EU member states halted the rollout of AstraZeneca vaccines after reports of several serious cases of blood clots.

The EMA and World Health Organization (WHO) subsequently stated that the vaccine was “safe and effective” and that the benefits of the jab outweighed any risk of side effects.

EMA executive director Emer Cooke also stated that cases of thrombosis were not an “unexpected” situation when millions of people are being vaccinated.

There were just seven cases of the tiny clots and eighteen cases of the other blood condition out of 20 million people vaccinated, according to EMA.

Italy, France, Germany, and Spain have since restarted AstraZeneca vaccinations after the highly-anticipated safety review, but Denmark, Norway, and Sweden initially remained hesitant.

In a statement, Denmark’s health authority noted that the EMA could not “definitively rule out” a link between the vaccine and blood clotting.

“We have started several studies and talked to experts in the affected areas, so we are sure to uncover the scope and the possible connection,” said Søren Brostrøm, director of the Danish National Board of Health.

“At present, we believe that our basis for making a final decision on the further use of the COVID-19 vaccine from AstraZeneca is too uncertain.”

“Many studies have been launched, but we do not yet have any conclusions. That is why we have decided to extend the break,” he added.

The Danish Health Authority stated that they would provide an update on their decision in mid-April, and acknowledged that their decision had slowed the vaccination process in the country.

“We are very aware that a continued suspension of vaccination with the COVID-19 vaccine from AstraZeneca is delaying the Danish vaccination program against COVID-19,” said Brostrøm.

“However, we have the vaccines in the refrigerator, and if we decide to start vaccination with the COVID-19 vaccine from AstraZeneca again, we can quickly distribute and use the vaccines.”

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from Zero Hedge


Articles by: Euronews

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]lresearch.ca